Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis - Noureddin, M; Jones, C; Alkhouri, N (Gastroenterology, 2020)